[S06] Toward the next generation of vaccines (AMED-SCARDA) | The 22nd Awaji International Forum on Infection and Immunity

Session Details

Symposium

[S06]Toward the next generation of vaccines (AMED-SCARDA)

Thu. Sep 19, 2024 10:30 AM - 12:40 PM JST
Thu. Sep 19, 2024 1:30 AM - 3:40 AM UTC

Lecture Hall(South Hall)

Chairs:Hisashi Arase(Research Institute for Microbial Diseases, Osaka University), Yasuo Yoshioka(Research Institute for Microbial Diseases, Osaka University)

10:30 AM - 10:55 AM JST(1:30 AM - 1:55 AM UTC)

[S06-1]The use of RNA biology of mammarenavirus for vaccine development

○Masaharu Iwasaki^1,2,3,4 (1. Laboratory of Emerging Viral Diseases, International Research Center for Infectious Diseases, Research Institute for Microbial Diseases, Osaka University (Japan), 2. Center for Infectious Disease Education and Research, Osaka University (Japan), 3. Center for Advanced Modalities and Drug Delivery System, Osaka University (Japan), 4. RNA Frontier Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University (Japan))

Comment()

10:55 AM - 11:10 AM JST(1:55 AM - 2:10 AM UTC)

[S06-2 (P107)]Versatile and scalable nanoparticle vaccine as a scaffold against newly emerging influenza viruses

○Alessandro Pardini^1,2,3, Dominik Alexander Rothen^1,2,3, Pascal Sigfried Krenger^1,2,3, Anne-Cathrine Sarah Vogt^1,2,3, Romano Josi^1,2,3, Monique Vogel^1,2, Manfred Kopf⁴, Martin Fabian Bachmann^1,2,5 (1. Department of BioMedical Research, University of Bern, Bern, (Switzerland), 2. Department of Rheumatology and Immunology, University Hospital Bern, Bern, (Switzerland), 3. Graduate School of Cellular and Biomedical Sciences, University of Bern, Bern, (Switzerland), 4. Institute of Molecular Health Sciences, ETH Zurich, Zurich (Switzerland), 5. Nuffield Department of Medicine, Centre for Cellular and Molecular Physiology (CCMP), The Jenner Institute, University of Oxford, Oxford, (UK))

Comment()

11:10 AM - 11:35 AM JST(2:10 AM - 2:35 AM UTC)

[S06-3]From virus evolution to enterovirus vaccines

○Ming Te Yeh¹, Raul Andino² (1. Osaka University (Japan), 2. University of California San Francisco (United States of America))

Comment()

11:35 AM - 11:45 AM JST(2:35 AM - 2:45 AM UTC)

[S06-4 (P111)]Single-particle biology using nanoflow cytometry as an alternatice to single-cell biology for advanced immunological insights

○Shuntaro Shimizu^1,2,3,4, Tomoya Hayashi^1,2,3, Koji Sakamoto⁵, Naozumi Hashimoto⁶, Kouji Kobiyama^1,2,3, Hideo Negishi^1,2,3, Burcu Temizoz^1,2,3, Cevayir Coban^2,3,7, Ken Ishii^1,2,3 (1. Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo (IMSUT), Tokyo, Japan (Japan), 2. International Vaccine Design Center, IMSUT, Tokyo, Japan (Japan), 3. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Japan (Japan), 4. Department of Chemistry, Chemical Engineering & Life Science, Yokohama National University, Kanagawa, Japan (Japan), 5. Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan (Japan), 6. Department of Respiratory Medicine, Fujita Health University, Nagoya, Japan (Japan), 7. Division of Malaria Immunology, Department of Microbiology and Immunology, IMSUT, Tokyo, Japan (Japan))

Comment()

11:45 AM - 12:15 PM JST(2:45 AM - 3:15 AM UTC)

[S06-5]Role of apoptosis in affinity maturation and selection of B cells in germinal centers

○Masayuki Kuraoka¹ (1. Duke University (United States of America))

Comment()

12:15 PM - 12:40 PM JST(3:15 AM - 3:40 AM UTC)

[S06-6]Development of intracellular environment-responsive lipid like material (ssPalm) for the in vivo immune regulation towards RNA-based therapeutics

○Hidetaka Akita^1,2 (1. Graduate School of Pharmaceutical Sciences, Tokoku University (Japan), 2. Center for Advanced Modalities and DDS, Osaka University (Japan))

Comment()

Back to Category List